Processa Pharmaceuticals (PCSA) Operating Leases (2019 - 2024)
Processa Pharmaceuticals' (PCSA) quarterly Operating Leases came in at $487.0 in Q4 2024, down 99.27% YoY from $66905.0 in Q1 2024, and down 77.54% on a QoQ basis from $2168.0 in Q3 2024.
Processa Pharmaceuticals (PCSA) Operating Leases (2019 - 2024) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 6 years of Operating Leases data on file, last reported at $487.0 in Q4 2024.
- Quarterly Operating Leases fell 99.27% year-over-year to $487.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $487.0 (down 99.27% YoY) and the FY2024 annual result came in at $487.0, down 99.27% from the prior year.
- Operating Leases declined to $487.0 in Q4 2024, from $2168.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $186562.0 in Q2 2020 to a low of $487.0 in Q4 2024.
- A 5-year average of $79370.5 and a median of $72684.0 in 2020 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases soared 2004.41% — and 2024, when it slumped 99.27%.
- Tracing PCSA's Operating Leases over 5 years: stood at $78463.0 in 2020, then slumped by 90.59% to $7385.0 in 2021, then jumped by 1938.65% to $150554.0 in 2022, then tumbled by 55.56% to $66905.0 in 2023, then tumbled by 99.27% to $487.0 in 2024.
- The last three Operating Leases figures came in at $487.0 (Q4 2024), $2168.0 (Q3 2024), and $25648.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 487.00 |
| Sep 30, 2024 | 2,168.00 |
| Jun 30, 2024 | 25,648.00 |
| Mar 31, 2024 | 50,700.00 |
| Dec 31, 2023 | 66,905.00 |
| Sep 30, 2023 | 171,521.00 |
| Jun 30, 2023 | 109,327.00 |
| Mar 31, 2023 | 129,358.00 |
| Dec 31, 2022 | 150,554.00 |
| Sep 30, 2022 | 171,707.00 |
| Jun 30, 2022 | 31,207.00 |
| Mar 31, 2022 | 6,147.00 |
| Dec 31, 2021 | 7,385.00 |
| Sep 30, 2021 | 8,773.00 |
| Jun 30, 2021 | 30,896.00 |
| Mar 31, 2021 | 144,714.00 |
| Dec 31, 2020 | 78,463.00 |
| Sep 30, 2020 | 86,736.00 |
| Jun 30, 2020 | 186,562.00 |
| Mar 31, 2020 | 128,152.00 |